PTPI
Petros Pharmaceuticals, Inc.
Price Chart
Latest Quote
$0.01
+0.00 (+0.00%)
Current Price
| Previous Close | $0.01 |
| Open | $0.01 |
| Day High | $0.01 |
| Day Low | $0.01 |
| Volume | 12,616 |
Stock Information
| Shares Outstanding | 42.37M |
| Cash Equivalents | $4.35M |
| Net Income | $-41.49M |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Market Cap | $254K |
| P/E Ratio | 0.00 |
| EPS (TTM) | $6.64 |
| Exchange | PNK |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $-4.10M |
| Income | $-41.49M |
| Book/sh | $0.07 |
| Cash/sh | $0.10 |
| Employees | 3 |
Financial Ratios
| Quick Ratio | 1.66 |
| Current Ratio | 1.68 |
Returns & Margins
| ROA | -23.92% |
Ownership
| Insider Ownership | 24.08% |
| Institutional Ownership | 10.24% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -0.01 |
| P/B | 0.09 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.01 |
| SMA50 | $0.01 |
| SMA200 | $0.01 |
| RSI | 50.00 |
| ATR | 0.0015 |
| Shares Float | 36.25M |
| Short Float | 25.07% |
| Short Ratio | 0.17 |
| Rel Volume | 0.30 |
Performance History
| Week | -14.29% |
| Month | -14.29% |
| Quarter | -14.29% |
| 6 Months | -50.00% |
| YTD | -25.00% |
| Year | -80.00% |
| 3 Years | -99.99% |
| 5 Years | -100.00% |
| 10 Years | -100.00% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $0.01 | 24,400 |
| 2026-06-17 | $0.01 | 19,300 |
| 2026-06-16 | $0.01 | 47,800 |
| 2026-06-15 | $0.01 | 45,700 |
| 2026-06-12 | $0.01 | 114,300 |
| 2026-06-11 | $0.01 | 19,500 |
| 2026-06-10 | $0.01 | 94,900 |
| 2026-06-09 | $0.01 | 465,600 |
| 2026-06-08 | $0.01 | 22,100 |
| 2026-06-05 | $0.01 | 24,700 |
| 2026-06-04 | $0.01 | 119,100 |
| 2026-06-03 | $0.01 | 105,900 |
| 2026-06-02 | $0.01 | 66,000 |
| 2026-06-01 | $0.01 | 80,600 |
| 2026-05-29 | $0.01 | 31,300 |
| 2026-05-28 | $0.01 | 63,000 |
| 2026-05-27 | $0.01 | 91,700 |
| 2026-05-26 | $0.01 | 41,200 |
| 2026-05-22 | $0.01 | 93,200 |
| 2026-05-21 | $0.01 | 52,500 |
| 2026-05-20 | $0.01 | 19,700 |
| 2026-05-19 | $0.01 | 51,500 |
About Petros Pharmaceuticals, Inc.
Petros Pharmaceuticals, Inc., a healthcare technology company, focuses on developing and licensing proprietary software as a service (SaaS) platform and Software as a medical device web application designed to assist pharmaceutical companies. The company is based in New York, New York.
Period:
Loading...
Income Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $1,100,171 | $1,499,008 | $2,172,333 | $1,599,566 |
| Cost Of Revenue | $1,212,700 | $1,631,220 | $2,289,418 | $1,599,566 |
| Total Revenue | $5,112,043 | $5,822,388 | $5,992,054 | $7,811,264 |
| Operating Revenue | $5,112,043 | $5,822,388 | $5,992,054 | $7,811,264 |
| Expenses | ||||
| Interest Expense | $560,909 | $536,138 | $596,018 | $368,660 |
| Total Expenses | $15,408,071 | $16,584,752 | $21,837,744 | $25,859,280 |
| Other Income Expense | $-3,833,622 | $2,620,003 | $-3,610,059 | $9,430,000 |
| Net Non Operating Interest Income Expense | $-189,140 | $-20,827 | $-581,824 | $-368,660 |
| Interest Expense Non Operating | $560,909 | $536,138 | $596,018 | $368,660 |
| Operating Expense | $14,195,371 | $14,953,532 | $19,548,326 | $24,259,714 |
| Other Non Operating Income Expenses | - | $-11,088,997 | $3,389,941 | - |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-14,318,790 | $-8,163,188 | $-20,037,573 | $-8,986,676 |
| Net Interest Income | $-189,140 | $-20,827 | $-581,824 | $-368,660 |
| Interest Income | $371,769 | $515,311 | $14,194 | $0 |
| Normalized Income | $-10,485,168 | $-21,872,188 | $-13,037,573 | $-18,416,676 |
| Net Income From Continuing And Discontinued Operation | $-14,318,790 | $-8,163,188 | $-20,037,573 | $-8,986,676 |
| Total Operating Income As Reported | $-17,679,650 | $-13,617,364 | $-19,915,749 | $-18,048,016 |
| Net Income Common Stockholders | $-26,797,159 | $-13,814,399 | $-20,037,573 | $-8,986,676 |
| Net Income | $-14,318,790 | $-8,163,188 | $-20,037,573 | $-8,986,676 |
| Net Income Including Noncontrolling Interests | $-14,318,790 | $-8,163,188 | $-20,037,573 | $-8,986,676 |
| Net Income Continuous Operations | $-14,318,790 | $-8,163,188 | $-20,037,573 | $-8,986,676 |
| Pretax Income | $-14,318,790 | $-8,163,188 | $-20,037,573 | $-8,986,676 |
| Special Income Charges | $-7,383,622 | $0 | $-7,460,000 | $0 |
| Interest Income Non Operating | $371,769 | $515,311 | $14,194 | $0 |
| Operating Income | $-10,296,028 | $-10,762,364 | $-15,845,690 | $-18,048,016 |
| Depreciation Amortization Depletion Income Statement | $2,831,219 | $3,282,967 | $5,598,884 | $6,877,990 |
| Depreciation And Amortization In Income Statement | $2,831,219 | $3,282,967 | $5,598,884 | $6,877,990 |
| Gross Profit | $3,899,343 | $4,191,168 | $3,702,636 | $6,211,698 |
| Per Share | ||||
| Diluted EPS | $-83.50 | $-158.75 | $-242.00 | $-206.25 |
| Basic EPS | $-83.50 | $-158.75 | $-242.00 | $-206.25 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-6,980,511 | $-17,920,871 | $-6,725,586 | $-11,170,026 |
| Total Unusual Items | $-3,833,622 | $13,709,000 | $-7,000,000 | $9,430,000 |
| Total Unusual Items Excluding Goodwill | $-3,833,622 | $13,709,000 | $-7,000,000 | $9,430,000 |
| Reconciled Depreciation | $2,943,748 | $3,415,179 | $5,715,969 | $6,877,990 |
| EBITDA (Bullshit earnings) | $-10,814,133 | $-4,211,871 | $-13,725,586 | $-1,740,026 |
| EBIT | $-13,757,881 | $-7,627,050 | $-19,441,555 | $-8,618,016 |
| Diluted Average Shares | $321,041 | $87,040 | $82,808 | $43,559 |
| Basic Average Shares | $321,041 | $87,040 | $82,808 | $43,559 |
| Diluted NI Availto Com Stockholders | $-26,797,159 | $-13,814,399 | $-20,037,573 | $-8,986,676 |
| Otherunder Preferred Stock Dividend | $10,170,247 | $4,829,755 | $0 | - |
| Preferred Stock Dividends | $2,308,122 | $821,456 | - | - |
| Tax Provision | $0 | $0 | $0 | $0 |
| Impairment Of Capital Assets | $7,383,622 | $0 | $7,460,000 | $0 |
| Gain On Sale Of Security | $3,550,000 | $13,709,000 | $460,000 | $9,430,000 |
| Research And Development | $2,615,050 | $2,409,094 | $1,740,280 | $1,788,491 |
| Selling General And Administration | $8,749,102 | $9,261,471 | $12,209,162 | $15,593,233 |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-10,671,932 | $3,508,286 | $4,457,983 | $10,251,815 |
| Total Assets | $10,635,310 | $33,795,795 | $32,421,214 | $67,390,058 |
| Total Non Current Assets | $3,341,032 | $13,405,399 | $17,753,309 | $36,847,363 |
| Goodwill And Other Intangible Assets | $3,204,354 | $8,971,737 | $12,244,484 | $25,293,149 |
| Current Assets | $7,294,278 | $20,390,396 | $14,667,905 | $30,542,695 |
| Other Current Assets | $6,532 | $816,205 | $802,210 | $1,529,705 |
| Prepaid Assets | $1,811,897 | $2,400,674 | $514,072 | $1,581,324 |
| Inventory | $1,349,802 | $1,610,391 | $1,815,113 | $519,649 |
| Receivables | $416,076 | $2,226,151 | $2,110,246 | $3,064,445 |
| Accounts Receivable | $416,076 | $2,226,151 | $2,110,246 | $2,455,386 |
| Allowance For Doubtful Accounts Receivable | $-165,376 | $-661,166 | $-647,593 | $-908,441 |
| Gross Accounts Receivable | $581,452 | $2,887,317 | $2,757,839 | $3,363,827 |
| Cash Cash Equivalents And Short Term Investments | $3,709,971 | $13,336,975 | $9,426,264 | $23,847,572 |
| Cash And Cash Equivalents | $3,709,971 | $13,336,975 | $9,426,264 | $23,847,572 |
| Other Non Current Assets | - | $4,178,446 | $5,111,176 | $11,029,260 |
| Cash Financial | - | $13,336,975 | $9,426,264 | $23,847,572 |
| Other Receivables | - | - | - | $609,059 |
| Debt | ||||
| Net Debt | $3,538,664 | - | $51,512 | - |
| Total Debt | $7,386,291 | $8,276,593 | $9,882,794 | $405,018 |
| Long Term Debt And Capital Lease Obligation | $75,223 | $6,995,021 | $8,650,771 | $405,018 |
| Current Debt And Capital Lease Obligation | $7,311,068 | $1,281,572 | $1,232,023 | - |
| Current Debt | $7,248,635 | $1,156,550 | $1,089,683 | - |
| Long Term Debt | - | $6,857,364 | $8,388,093 | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $18,102,888 | $21,315,772 | $15,718,747 | $31,845,094 |
| Total Non Current Liabilities Net Minority Interest | $75,223 | $10,545,021 | $8,650,771 | $865,018 |
| Derivative Product Liabilities | $0 | $3,550,000 | $0 | $460,000 |
| Current Liabilities | $18,027,665 | $10,770,751 | $7,067,976 | $30,980,076 |
| Other Current Liabilities | $15,733 | $368,266 | $394,892 | $260,818 |
| Current Deferred Liabilities | $1,909,496 | $2,047,583 | $0 | - |
| Current Notes Payable | $7,248,635 | $1,156,550 | $1,089,683 | $0 |
| Payables And Accrued Expenses | $8,791,368 | $6,408,146 | $5,013,561 | $30,191,695 |
| Interest Payable | $326,189 | $0 | - | - |
| Payables | $2,402,737 | $1,788,980 | $1,961,480 | $7,304,670 |
| Other Payable | $73,773 | $75,727 | $155,081 | $2,746,701 |
| Accounts Payable | $2,328,964 | $1,713,253 | $1,806,399 | $4,557,969 |
| Equity | ||||
| Common Stock Equity | $-7,467,578 | $12,071,041 | $16,702,467 | $35,544,964 |
| Total Equity Gross Minority Interest | $-7,467,578 | $12,480,023 | $16,702,467 | $35,544,964 |
| Stockholders Equity | $-7,467,578 | $12,480,023 | $16,702,467 | $35,544,964 |
| Retained Earnings | $-113,208,371 | $-98,889,581 | $-90,726,393 | $-70,688,820 |
| Preferred Stock Equity | - | $408,982 | - | - |
| Other | ||||
| Ordinary Shares Number | $421,124 | $119,655 | $83,175 | $82,738 |
| Share Issued | $421,124 | $119,655 | $83,175 | $82,738 |
| Tangible Book Value | $-10,671,932 | $3,099,304 | $4,457,983 | $10,251,815 |
| Invested Capital | $-218,943 | $20,084,955 | $26,180,243 | $35,544,964 |
| Working Capital | $-10,733,387 | $9,619,645 | $7,599,929 | $-437,381 |
| Capital Lease Obligations | $137,656 | $262,679 | $405,018 | $405,018 |
| Total Capitalization | $-7,467,578 | $19,337,387 | $25,090,560 | $35,544,964 |
| Additional Paid In Capital | $105,739,740 | $110,960,324 | $107,428,652 | $106,233,577 |
| Capital Stock | $1,053 | $409,280 | $208 | $207 |
| Common Stock | $1,053 | $298 | $208 | $207 |
| Preferred Stock | $0 | $408,982 | $0 | $0 |
| Long Term Capital Lease Obligation | $75,223 | $137,657 | $262,678 | $405,018 |
| Current Deferred Revenue | $1,909,496 | $2,047,583 | $0 | - |
| Current Capital Lease Obligation | $62,433 | $125,022 | $142,340 | - |
| Pensionand Other Post Retirement Benefit Plans Current | $0 | $665,184 | $427,500 | $527,563 |
| Current Accrued Expenses | $6,388,631 | $4,619,166 | $3,052,081 | $22,887,025 |
| Net PPE | $136,678 | $255,216 | $397,649 | $524,954 |
| Gross PPE | $136,678 | $255,216 | $397,649 | $524,954 |
| Leases | $113,730 | $226,259 | $358,472 | $475,557 |
| Machinery Furniture Equipment | $22,948 | $28,957 | $39,177 | $49,397 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $85,912 | $180,252 | $240,430 | $159,908 |
| Raw Materials | $1,263,890 | $1,430,139 | $1,574,683 | $359,741 |
| Buildings And Improvements | - | - | $358,472 | $475,557 |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-2,627,638 | $-7,626,529 | $-12,797,325 | $-11,862,031 |
| Operating Activities | ||||
| Operating Cash Flow | $-2,603,051 | $-7,626,529 | $-12,797,325 | $-11,862,031 |
| Cash Flow From Continuing Operating Activities | $-2,603,051 | $-7,626,529 | $-12,797,325 | $-11,862,031 |
| Operating Gains Losses | $-3,550,000 | $-14,969,000 | $-460,000 | $-9,430,000 |
| Investing Activities | ||||
| Capital Expenditure | $-24,587 | - | - | - |
| Investing Cash Flow | $-24,587 | $0 | - | $0 |
| Cash Flow From Continuing Investing Activities | $-24,587 | $0 | - | $0 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-6,234,087 | $-1,998,901 | $0 | - |
| Financing Cash Flow | $-6,999,366 | $11,537,240 | $-1,623,983 | $18,569,909 |
| Cash Flow From Continuing Financing Activities | $-6,999,366 | $11,537,240 | $-1,623,983 | $18,569,909 |
| Net Preferred Stock Issuance | $-6,234,087 | $-1,998,901 | $0 | - |
| Net Other Financing Charges | - | $15,000,003 | - | - |
| Issuance Of Capital Stock | - | - | $0 | $21,745,003 |
| Net Common Stock Issuance | - | - | $0 | $21,745,003 |
| Common Stock Issuance | - | - | $0 | $21,745,003 |
| Other | ||||
| Repayment Of Debt | $-765,279 | $-1,463,862 | $-1,623,983 | $-7,187,529 |
| Interest Paid Supplemental Data | $234,721 | $536,138 | $596,018 | $421,821 |
| End Cash Position | $3,709,971 | $13,336,975 | $9,426,264 | $23,847,572 |
| Beginning Cash Position | $13,336,975 | $9,426,264 | $23,847,572 | $17,139,694 |
| Changes In Cash | $-9,627,004 | $3,910,711 | $-14,421,308 | $6,707,878 |
| Preferred Stock Payments | $-6,234,087 | $-1,998,901 | $0 | - |
| Net Issuance Payments Of Debt | $-765,279 | $-1,463,862 | $-1,623,983 | $-7,187,529 |
| Net Long Term Debt Issuance | $-765,279 | $-1,463,862 | $-1,623,983 | $-7,187,529 |
| Long Term Debt Payments | $-765,279 | $-1,463,862 | $-1,623,983 | $-7,187,529 |
| Net PPE Purchase And Sale | $-24,587 | $0 | - | $0 |
| Purchase Of PPE | $-24,587 | $0 | - | $0 |
| Change In Working Capital | $4,526,731 | $624,914 | $-3,302,071 | $-1,763,950 |
| Change In Other Working Capital | $-117,238 | $-164,133 | - | - |
| Change In Other Current Liabilities | $-360,318 | $-4,831 | $-76,971 | $-227,193 |
| Change In Payables And Accrued Expense | $1,718,012 | $1,632,267 | $-4,553,992 | $-3,777,990 |
| Change In Accrued Expense | $1,102,327 | $1,725,415 | $-1,802,422 | $-2,726,403 |
| Change In Payable | $615,685 | $-93,148 | $-2,751,570 | $-1,051,587 |
| Change In Account Payable | $615,685 | $-93,148 | $-2,751,570 | $-1,051,587 |
| Change In Prepaid Assets | $1,160,034 | $-967,867 | $1,648,252 | $-720,209 |
| Change In Inventory | $307,592 | $273,611 | $-835,317 | $412,744 |
| Change In Receivables | $1,818,649 | $-144,133 | $515,957 | $2,548,698 |
| Changes In Account Receivables | $1,818,649 | $-144,133 | $515,957 | $2,548,698 |
| Other Non Cash Items | $270,000 | $11,088,997 | $-3,178,912 | $186,821 |
| Stock Based Compensation | $197,215 | $417,230 | $1,195,076 | $1,305,150 |
| Provisionand Write Offof Assets | $-47,003 | $-68,889 | $-18,998 | $-200,251 |
| Asset Impairment Charge | $7,375,048 | $28,228 | $7,289,184 | $148,885 |
| Depreciation Amortization Depletion | $2,943,748 | $3,415,179 | $5,715,969 | $6,877,990 |
| Depreciation And Amortization | $2,943,748 | $3,415,179 | $5,715,969 | $6,877,990 |
| Depreciation | $2,943,748 | $3,415,179 | $5,715,969 | $6,877,990 |
| Gain Loss On Investment Securities | $-3,550,000 | $-14,969,000 | $-460,000 | $-9,430,000 |
| Net Income From Continuing Operations | $-14,318,790 | $-8,163,188 | $-20,037,573 | $-8,986,676 |
| Proceeds From Stock Option Exercised | - | - | $0 | $4,012,435 |
| Issuance Of Debt | - | - | - | $0 |
| Long Term Debt Issuance | - | - | - | $0 |
| Deferred Tax | - | - | - | $0 |
| Deferred Income Tax | - | - | - | $0 |
Fetched: 2026-02-02